Characteristics associated with the residual risk of severe COVID-19 after a complete vaccination schedule: A cohort study of 28 million people in France

by Baricault, B., Bertrand, M., Botton, J., Cuenot, F., Dray-Spira, R., Drouin, J., Jabagi, M.-J, Semenzato, L., Vu, S.L, Weill, A., Zureik, M.
Published 2022

Respiratory Infections and Anti-Infective Medication Use From Phase 3 Dupilumab Respiratory Studies

by Bachert, C., Busse, W.W, Chen, Z., Deniz, Y., Geng, B., Gevaert, P., Jacob-Nara, J.A, Kapoor, U., Khokhar, F.A, Lee, S.E, Lu, X., Niederman, M.S, Ortiz, B., Pandit-Abid, N., Rowe, P.J
Published 2022